{"disease":{"id":"diabetic-foot-infection","name":"Diabetic Foot Infection","therapeutic_area":"","data":{},"enrichment_level":0,"last_enriched_at":null,"visit_count":0,"created_at":"2026-04-19T18:31:21.150Z","updated_at":"2026-04-19T18:39:44.960Z","meddra_pt":null,"meddra_code":null,"icd10_codes":null,"synonyms":[],"prevalence_global":null,"prevalence_us":null,"marketed_drug_count":5,"pipeline_drug_count":0,"trial_count":0},"drugs":{"marketed":[{"drug_id":"piperacillin","indication_name":"Diabetic Foot Infection","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Pipracil","generic_name":"PIPERACILLIN","company_name":"","drug_phase":"marketed","molecular_target":"","drug_class":"piperacillin","quality_score":10,"revenue":null,"mechanism":"Pipracil works by inhibiting bacterial cell wall synthesis, ultimately leading to cell lysis and death."},{"drug_id":"ertapenem","indication_name":"Diabetic Foot Infection","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Invanz","generic_name":"ERTAPENEM","company_name":"Merck & Co.","drug_phase":"marketed","molecular_target":"","drug_class":"Penem Antibacterial","quality_score":70,"revenue":null,"mechanism":"Invanz works by inhibiting bacterial cell wall synthesis, ultimately leading to bacterial cell death."},{"drug_id":"imipenem","indication_name":"Diabetic Foot Infection","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Primaxin","generic_name":"IMIPENEM","company_name":"Merck Sharp & Dohme B.V.","drug_phase":"marketed","molecular_target":"","drug_class":"imipenem","quality_score":70,"revenue":null,"mechanism":"Primaxin works by inhibiting bacterial cell wall synthesis, ultimately leading to bacterial cell death."},{"drug_id":"cilastatin","indication_name":"Diabetic Foot Infection","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Primaxin","generic_name":"CILASTATIN","company_name":"Merck & Co.","drug_phase":"marketed","molecular_target":"Dipeptidase 1","drug_class":"Renal Dehydropeptidase Inhibitor","quality_score":65,"revenue":null,"mechanism":"Primaxin works by inhibiting the action of dehydropeptidase, an enzyme that breaks down certain antibiotics, thereby protecting them from degradation and allowing them to reach effective concentrations in the body."},{"drug_id":"linezolid","indication_name":"Diabetic Foot Infection Due to Gram-Positive Bacteria","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Zyvox","generic_name":"linezolid","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Amine oxidase [flavin-containing] A","drug_class":"Oxazolidinone Antibacterial [EPC]","quality_score":10,"revenue":null,"mechanism":"Zyvox works by inhibiting the bacterial protein synthesis initiation complex, preventing the growth and replication of Gram-positive bacteria."},{"drug_id":"tazobactam","indication_name":"Diabetic Foot Infection","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Zosyn","generic_name":"TAZOBACTAM","company_name":"Merck Sharp & Dohme B.V.","drug_phase":"marketed","molecular_target":"","drug_class":"beta Lactamase Inhibitor","quality_score":50,"revenue":null,"mechanism":"Zosyn works by blocking bacterial enzymes that break down antibiotics, allowing the antibiotics to kill bacteria more effectively."}],"pipeline":[],"offLabel":[],"totalMarketed":6,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06526884","title":"Quasi-Randomized Evaluation of the UCLA Next Day Clinic (NDC)","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":1080,"lead_sponsor_name":"University of California, Los Angeles","has_results":false},{"nct_id":"NCT05369052","title":"Safety and Efficacy Study of Contezolid Acefosamil and Contezolid Compared to Linezolid Administered Intravenously and Orally to Adults With Moderate or Severe Diabetic Foot Infections (DFI)","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":865,"lead_sponsor_name":"MicuRx","has_results":false},{"nct_id":"NCT04081792","title":"Optimal Antibiotics for Operated Diabetic Foot Infections","phase":"NA","overall_status":"COMPLETED","enrollment_count":643,"lead_sponsor_name":"Balgrist University Hospital","has_results":false},{"nct_id":"NCT05172089","title":"Diabetic Foot Ulcer (DFU) Biofilm Infection and Recurrence","phase":"","overall_status":"RECRUITING","enrollment_count":405,"lead_sponsor_name":"University of Pittsburgh","has_results":false},{"nct_id":"NCT04141787","title":"Ceftriaxone as Home IV for Staph Infections","phase":"PHASE4","overall_status":"UNKNOWN","enrollment_count":310,"lead_sponsor_name":"Vancouver Island Health Authority","has_results":false},{"nct_id":"NCT04176120","title":"Cryopreserved Human Umbilical Cord (TTAX01) for Late Stage, Complex Non-healing Diabetic Foot Ulcers (AMBULATE DFU)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":220,"lead_sponsor_name":"BioTissue Holdings, Inc","has_results":false},{"nct_id":"NCT06667752","title":"Randomized Double-Blind Trial on Safety and Efficacy of Nanordica Advanced Antibacterial Wound Dressing for Diabetic Foot Ulcer","phase":"NA","overall_status":"RECRUITING","enrollment_count":170,"lead_sponsor_name":"Nanordica Medical OU","has_results":false},{"nct_id":"NCT07040488","title":"Study of Infrared Thermography in Diabetic Foot in Guadeloupe","phase":"","overall_status":"RECRUITING","enrollment_count":150,"lead_sponsor_name":"Centre Hospitalier Universitaire de la Guadeloupe","has_results":false},{"nct_id":"NCT05726006","title":"Invasive Group B Streptococcus Disease Burden and Its Antimicrobial Resistance in Malaysia Among Non-pregnant Adults.","phase":"","overall_status":"UNKNOWN","enrollment_count":133,"lead_sponsor_name":"Universiti Putra Malaysia","has_results":false},{"nct_id":"NCT04440839","title":"Implementation of Telemedicine for Patient With Lower Extremity Wounds","phase":"NA","overall_status":"COMPLETED","enrollment_count":116,"lead_sponsor_name":"University of California, Davis","has_results":true},{"nct_id":"NCT04450693","title":"Cryopreserved Human Umbilical Cord (TTAX01) for Late Stage, Complex Non-healing Diabetic Foot Ulcers (AMBULATE DFU II)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":106,"lead_sponsor_name":"BioTissue Holdings, Inc","has_results":false},{"nct_id":"NCT05855980","title":"Toe Amputations in Patients With Diabetes","phase":"NA","overall_status":"UNKNOWN","enrollment_count":102,"lead_sponsor_name":"Tampere University Hospital","has_results":false},{"nct_id":"NCT03495349","title":"Effectiveness and Safety of Antibiotherapy in Diabetic Patients Treated for a Diabetic Foot Infection.","phase":"","overall_status":"COMPLETED","enrollment_count":102,"lead_sponsor_name":"Hospices Civils de Lyon","has_results":false},{"nct_id":"NCT05616351","title":"Antibiotic Therapy in Infections of the Diabetic Foot Syndrome","phase":"","overall_status":"COMPLETED","enrollment_count":80,"lead_sponsor_name":"University Hospital, Basel, Switzerland","has_results":false},{"nct_id":"NCT05613985","title":"PHOTOFINISH: a Clinical Study To Evaluate The Efficacy And Safety Of the System VULNOFAST® Plus/VULNOLIGHT® In Addition To The Usual Care (UC) Vs UC Alone For The Treatment Of Infected Diabetic Foot Ulcers","phase":"NA","overall_status":"RECRUITING","enrollment_count":78,"lead_sponsor_name":"L.Molteni & C. dei F.lli Alitti-Soc. di Esercizio S.p.A.","has_results":false},{"nct_id":"NCT05948592","title":"Bacteriophage Therapy TP-102 in Patients With Diabetic Foot Infection","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":76,"lead_sponsor_name":"Technophage, SA","has_results":false},{"nct_id":"NCT03964571","title":"Human and Bacterial Protease Activity As Prognostic Tool of Foot Infections in Diabetic Patients","phase":"NA","overall_status":"COMPLETED","enrollment_count":61,"lead_sponsor_name":"Centre Hospitalier Universitaire de Nīmes","has_results":false},{"nct_id":"NCT02723539","title":"A Trial to Assess Safety and Efficacy of Topical MBN-101 in Patients With Moderate/ Severe DFI","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":52,"lead_sponsor_name":"Microbion Corporation","has_results":false},{"nct_id":"NCT05174806","title":"Multi-center Study to Assess Safety, Tolerability and Efficacy of Topical Pravibismane in Moderate DFI Patients","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":47,"lead_sponsor_name":"Microbion Corporation","has_results":false},{"nct_id":"NCT04714411","title":"Real-World Efficacy and Safety Analysis of Omadacycline for the Treatment of Diabetic Foot Infections and Acute Osteomyelitis","phase":"","overall_status":"COMPLETED","enrollment_count":42,"lead_sponsor_name":"Methodist Health System","has_results":false},{"nct_id":"NCT07338773","title":"Intraosseous vs. Intravenous Vancomycin Prophylaxis for Diabetic Foot Amputations: A Randomized Trial","phase":"PHASE4","overall_status":"RECRUITING","enrollment_count":40,"lead_sponsor_name":"Başakşehir Çam & Sakura City Hospital","has_results":false},{"nct_id":"NCT05564728","title":"Diabetes Footcare Companion App for Patients and Carers","phase":"","overall_status":"COMPLETED","enrollment_count":40,"lead_sponsor_name":"Nanyang Technological University","has_results":false},{"nct_id":"NCT05804565","title":"MetaMet: Bone Cutter Versus Bone Saw for Ray Amputation","phase":"NA","overall_status":"UNKNOWN","enrollment_count":40,"lead_sponsor_name":"University College Hospital Galway","has_results":false},{"nct_id":"NCT03380403","title":"A Clinical Trial Testing the Efficacy of PDT in Preventing Amputation in Diabetic Patients","phase":"NA","overall_status":"COMPLETED","enrollment_count":34,"lead_sponsor_name":"Faculdade de Medicina do ABC","has_results":false},{"nct_id":"NCT03230175","title":"Phase 2 Pilot Trial of Subjects With Complex Non-healing Diabetic Foot Ulcers Treated With Standard Care Plus Cryopreserved Umbilical Cord Allograft (TTAX01)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":32,"lead_sponsor_name":"BioTissue Holdings, Inc","has_results":true},{"nct_id":"NCT04240964","title":"Studying on the Difference Between Two Kinds of Osteomyelitis","phase":"","overall_status":"COMPLETED","enrollment_count":28,"lead_sponsor_name":"Nanfang Hospital, Southern Medical University","has_results":false},{"nct_id":"NCT04803708","title":"Bacteriophage Therapy TP-102 in Diabetic Foot Ulcers","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":20,"lead_sponsor_name":"Technophage, SA","has_results":false},{"nct_id":"NCT05243810","title":"EPC Silver Wound Gel (EPC-123) Feasibility Study in the Management of Mildly Infected Diabetic Foot Ulcers","phase":"NA","overall_status":"COMPLETED","enrollment_count":5,"lead_sponsor_name":"Exciton Technologies Inc.","has_results":false},{"nct_id":"NCT03712046","title":"Comparison of FDG PET and Bone Scintigraphy/Labelled Leukocyte/Gallium Scintigraphy in Diabetic Foot Osteomyelitis","phase":"NA","overall_status":"TERMINATED","enrollment_count":2,"lead_sponsor_name":"Centre hospitalier de l'Université de Montréal (CHUM)","has_results":false},{"nct_id":"NCT04289948","title":"Assessing the Efficacy of Anti-staphylococcal Phages in the Management of Infected Foot Ulcers in Diabetes","phase":"PHASE1, PHASE2","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"University Hospitals of Derby and Burton NHS Foundation Trust","has_results":false},{"nct_id":"NCT03827902","title":"Diabetic Foot Ulcer and Wound Infection","phase":"","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"University of Texas Southwestern Medical Center","has_results":false}],"total":31},"guidelines":[],"source":"Drug Landscape verified database"}